NEW YORK CITY, NY / ACCESS Newswire / July 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Simulations Plus, Inc. ("Simulations Plus" or the "Company") (NASDAQ:SLP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Simulations Plus and certain of its […]
NEW YORK CITY, NY / ACCESS Newswire / July 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of The J.M. Smucker Company ("Smucker" or the "Company") (NYSE:SJM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Smucker and certain of its officers
NEW YORK CITY, NY / ACCESS Newswire / July 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of GSK plc ("GSK" or the "Company") (NYSE:GSK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether GSK and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / July 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Geely Automobile Holdings Limited ("Geely" or the "Company") (OTCMKTS:GELYF; GELYY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Geely and certain of its
NEW YORK CITY, NY / ACCESS Newswire / July 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ:NUTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Nutex and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / July 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of MarineMax, Inc. ("MarineMax" or the "Company") (NYSE:HZO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether MarineMax and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / July 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Lockheed Martin Corporation ("Lockheed" or the "Company") (NYSE:LMT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Lockheed and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / July 30, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Fiserv, Inc. ("Fiserv" or the "Company") (NYSE:FI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK CITY, NY / ACCESS Newswire / July 30, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed on behalf of investors in Easterly ROCMuni High Income Municipal Bond Fund f/k/a Principal Street High Income Municipal Fund ("the Fund" or the "Company") (NASDAQ:RMHIX; RMHVX; RMJAX). Such investors are advised to
NEW YORK CITY, NY / ACCESS Newswire / July 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Neogen Corporation ("Neogen" or the "Company") (NASDAQ:NEOG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Neogen and certain of its officers and/or directors